Literature DB >> 29728706

A new platform for international collaboration on pharmacology and drug development: 2017 China-Canada-USA Pharmacology/Physiology Conference.

Zhong-Ping Feng1, Hong-Shuo Sun1,2,3.   

Abstract

Mesh：

Year:  2018        PMID： 29728706      PMCID： PMC5943916          DOI： 10.1038/aps.2018.34

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN： 1671-4083            Impact factor:   6.150


× No keyword cloud information.
  20 in total

Review 1.  Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

Authors:  Rachel J Harding; Yu-Feng Tong
Journal:  Acta Pharmacol Sin       Date:  2018-04-05       Impact factor: 6.150

2.  Xyloketal B exerts antihypertensive effect in renovascular hypertensive rats via the NO-sGC-cGMP pathway and calcium signaling.

Authors:  Li-Yan Zhao; Jie Li; Xiong-Qing Huang; Guo-Hao Wang; Xiao-Fei Lv; Wei-Feng Meng; Wen-Liang Chen; Ji-Yan Pang; Yong-Cheng Lin; Hong-Shuo Sun; Guan-Lei Wang; Yao-Min Du
Journal:  Acta Pharmacol Sin       Date:  2018-03-29       Impact factor: 6.150

3.  Blockade of the swelling-induced chloride current attenuates the mouse neonatal hypoxic-ischemic brain injury in vivo.

Authors:  Raymond Wong; Ahmed Abussaud; Joseph Wh Leung; Bao-Feng Xu; Fei-Ya Li; Sammen Huang; Nai-Hong Chen; Guan-Lei Wang; Zhong-Ping Feng; Hong-Shuo Sun
Journal:  Acta Pharmacol Sin       Date:  2018-03-29       Impact factor: 6.150

Review 4.  Phoenixin: uncovering its receptor, signaling and functions.

Authors:  Emma K Mcilwraith; Denise D Belsham
Journal:  Acta Pharmacol Sin       Date:  2018-04-19       Impact factor: 6.150

Review 5.  Organ preservation: from the past to the future.

Authors:  Lei Jing; Leeann Yao; Michael Zhao; Li-Ping Peng; Mingyao Liu
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

Review 6.  Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examples.

Authors:  Rui Xue Zhang; Jason Li; Tian Zhang; Mohammad A Amini; Chunsheng He; Brian Lu; Taksim Ahmed; HoYin Lip; Andrew M Rauth; Xiao Yu Wu
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

7.  MicroRNA expression profile and functional analysis reveal their roles in contact inhibition and its disruption switch of rat vascular smooth muscle cells.

Authors:  Ye-Ying Sun; Shan-Shan Qin; Yun-Hui Cheng; Chao-Yun Wang; Xiao-Jun Liu; Ying Liu; Xiu-Li Zhang; Wendy Zhang; Jia-Xin Zhan; Shuai Shao; Wei-Hua Bian; Bi-Hui Luo; Dong-Feng Lu; Jian Yang; Chun-Hua Wang; Chun-Xiang Zhang
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

Review 8.  Targeting RNS/caveolin-1/MMP signaling cascades to protect against cerebral ischemia-reperfusion injuries: potential application for drug discovery.

Authors:  Han-Sen Chen; Xi Chen; Wen-Ting Li; Jian-Gang Shen
Journal:  Acta Pharmacol Sin       Date:  2018-03-29       Impact factor: 6.150

Review 9.  TRPM2: a candidate therapeutic target for treating neurological diseases.

Authors:  Jillian Corinne Belrose; Michael Frederick Jackson
Journal:  Acta Pharmacol Sin       Date:  2018-04-19       Impact factor: 6.150

Review 10.  The role of TRPM2 channels in neurons, glial cells and the blood-brain barrier in cerebral ischemia and hypoxia.

Authors:  Ekaterina Turlova; Zhong-Ping Feng; Hong-Shuo Sun
Journal:  Acta Pharmacol Sin       Date:  2018-03-15       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.